Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMC812I)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Plasma retinol-binding protein (RBP4)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Tinlarebant	DM6JYUO	Stargardt disease	9B70	Phase 3	[2]
A1-10436	DM9ESPR	N. A.	N. A.	Patented	[3]
US9434727, 93	DMCJG8Z	N. A.	N. A.	Patented	[4]
US9434727, 40	DMLPWK3	N. A.	N. A.	Patented	[5]
US8586571, 12	DMKLJ6O	N. A.	N. A.	Patented	[6]
A1-10438	DMJD1S6	N. A.	N. A.	Patented	[3]
US8586571, 36	DMX3A0O	N. A.	N. A.	Patented	[6]
US8853215, 3	DMX8NLB	N. A.	N. A.	Patented	[3]
US8586571, 6	DM1N74R	N. A.	N. A.	Patented	[6]
US9434727, 120	DMIT0H3	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Plasma retinol-binding protein (RBP4)	TT0C8BY	RET4_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Substituted 4-phenylpiperidines, their preparation and use. US9434727.
2	Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development. Eur J Med Chem. 2021 Dec 15;226:113856.
3	Derivatives of N-acyl-N-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes. US8853215.
4	Substituted 4-phenylpiperidines, their preparation and use. US10072016.
5	Substituted 4-phenylpiperidines, their preparation and use. US9777010.
6	Heterocyclic compound. US8586571.